*The entire article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
With two earnings seasons of 2019 behind us, US Total Joints Market growth of 1.7% for H119, as modeled by SmartTRAK Financial Dashboard, is trending below SmartTRAK projections of 2.6% growth for FY19. This trend is not surprising considering the heightened seasonality we’ve seen over the last few years in H2 due to high patient deductibles. US Total Joints Market growth strengthened slightly to 1.8% for Q219 compared to 1.6% in Q1 driven by...
Among the many topics covered in the Q219 Total Joints Market Recap* are:
Robotics Influence Knee Implant Revenue Performance
Many Factors Influence Hip Performance
Regulatory Highlights
Outside of the usual bump up in Q4, SmartTRAK does not expect any major fluctuations in the market. While advanced technologies such as robotics have helped companies such as Stryker take share, they have not had a major effect on procedural growth. Looking ahead, CMS’s proposed reimbursement of total hips in a hospital outpatient setting and total knees in an ASC setting in 2020 is expected to accelerate the shift to outpatient procedures for appropriate patients...
Read the entire Q219 Total Joints Market Recap including news, data, company revenues and analysis*...
*The entire article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.